课题基金 / 基金详情

Detecting Opsoclonus-myoclonus-ataxia syndrome (OMAS): associations of novel eye tracking metrics with structural localizations in the midbrain

Detecting Opsoclonus-myoclonus-ataxia syndrome (OMAS): associations of novel eye tracking metrics with structural localizations in the midbrain
检测眼阵挛-肌阵挛-共济失调综合征（OMAS）：新颖的眼动追踪指标与中脑结构定位的关联
批准号：
466995
负责人：
Wu Susana
金额：
$1.27万
依托单位：
University of Toronto
依托单位国家：
加拿大
项目类别：
Studentship Programs
财政年份：
2021
资助国家：
加拿大
项目状态：
已结题
起止时间：
2021-12-01 至 2022-12-01
来源：
https://webapps.cihr-irsc.gc.ca/decisions/p/project_details.html?applId=466995&lang=en
关键词：
Autoimmune Disease Specific Biomarker Eye-Tracking Free Viewing Midbrain Neurological Novel Opsoclonus-Myoclonus-Ataxia Syndrome (Omas) Structural Localizations Superior Colliculus

项目摘要

项目成果

相似基金

相关文献

中文摘要
翻译
眼阵挛-肌阵挛-共济失调综合征(OMAS)是一种罕见但严重的炎症性神经系统疾病，通常影响幼儿，并极大地干扰他们的生活质量。有一些公认的免疫疗法已经被证明是高度有效的
英文摘要
Opsoclonus-myoclonus-ataxia syndrome (OMAS) is a rare but serious inflammatory neurological disorder that typically affects young children and greatly disturbs their quality of life. There are well-established immunotherapies that have shown to be highly
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
海外基金